Alpha Tau Medical DRTS
NASDAQ DRTS
$15.03 +0.41 (+2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTS) Net Equity Issued and Repurchased (2025)

Analysis

Alpha Tau Medical (DRTS) Net Equity Issued and Repurchased (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Alpha Tau Medical 1.21 Bn 1.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8.74 Mn